Zimbabwe has turned down a major US healthcare agreement worth $367m (272 million pounds) spanning five years due to the United States' request for sensitive data.
This rejection was revealed after a internal memorandum from December was leaked, revealing that Head of State Emmerson Mnangagwa deemed the deal was "skewed".
An official representative has since clarified that the United States was seeking genetic material for research and commercial purposes while refused to share the resulting advantages from any future treatments.
"We are forced to start the challenging and unfortunate process of winding down our support in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the US had furnished over $1.9bn as health assistance to Zimbabwe during the past twenty years.
A physicians' group in Zimbabwe has appealed for continued talks to find a deal agreeable to all parties so the country's critical HIV programme can proceed.
Broader Background
This rejection comes after a similar situation in neighbouring Kenya, where a high court halted a similar deal with the US following concerns were filed about the security of citizens' health data.
After resuming the presidency recently, US President Donald Trump has reduced overseas assistance and shut down the key foreign aid agency.
The agency had managed aid for the American government, but Trump argued its spending was "wasteful" and his government was pursuing government-to-government agreements to enhance transparency and responsibility.
Based on reports, Sixteen African countries have to date signed similar health pacts, representing more than $18.3bn in new funding.
Details of the Rejected Deal
This assistance for Zimbabwe would have supported "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this collaboration would have delivered significant benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children presently receiving HIV treatment through US-supported initiatives," Tremont said.
However, official spokesman Nick Mangwana maintained the arrangement was "unfair".
"Zimbabwe was being asked to provide its genetic material and health information over an extended period, with no corresponding assurance of benefiting from any medical innovations – such as vaccines, diagnostics, or treatments – that could result from that shared data," his statement read.
"In essence, our country would supply the basic resources for scientific discovery without any certainty that the resulting innovations would be accessible to our population if a new health crisis arise."
National Interest and International Frameworks
Mangwana further noted that the American exit from the World Health Organization (WHO) and its push of one-on-one health agreements were upending structures previously established via the international health agency.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing framework created to deal with potential global health emergencies.
"This framework is intended to guarantee that when a nation contributes its data, the resulting advantages – such as vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the resources to create them."
These objections over the US deal "are not meant as anti-American sentiment," he added.
"We encourage further discussions with our US partners on how future co-operation could be designed in a way that honours the independence and interests of both nations."
Health Experts Reaction
A leading public health body said it understood the official position, but recommended that talks should continue considering a large portion of the country's HIV programmes were funded by foreign aid.
"If technical issues exist, such as those relating to data governance or agreement terms, these can frequently be resolved through technical clarification and mutually agreed protections," the group said.
This impasse highlights the continuing challenges between accepting vital foreign assistance and protecting local interests in an ever more data-driven world.